LinX., ZamoraP.O., AlbrightS., et al. (2005). Multidomain synthetic peptide B2A2 synergistically enhances BMP-2 in vitro. J. Bone Miner. Res., 20, 693–703.
2.
ParelkarS.S., LetteriR., Chan-SengD., et al. (2014). Polymer-peptide delivery platforms: effect of oligopeptide orientation on polymer-based DNA delivery. Biomacromolecules, 15, 1328–1336.
3.
SuJ.L., LaiK.P., ChenC.A., et al. (2005). A novel peptide specifically binding to interleukin-6 receptor (gp80) inhibits angiogenesis and tumor growth. Cancer Res., 65, 4827–4835.
4.
ZolochevskaO., XiaX., WilliamsB.J., et al. (2011). Sonoporation delivery of interleukin 27 gene therapy efficiently reduces prostate tumor cell growth in vivo. Hum. Gene Ther., 22, 1537–1550.
5.
ZolochevskaO., ParelkarS., EllisJ., et al. (2013). Interleukin-27 gene delivery for modifying malignant interactions between prostate tumor and bone. Hum. Gene Ther., 24, 970–981.
